Publications by authors named "A Vismara"

Micro- and nanoplastics have become a significant concern, due to their ubiquitous presence in the environment. These particles can be internalized by the human body through ingestion, inhalation, or dermal contact, and then they can interact with environmental or biological molecules, such as proteins, resulting in the formation of the protein corona. However, information on the role of protein corona in the human body is still missing.

View Article and Find Full Text PDF
Article Synopsis
  • Ruxolitinib (RUX) is a treatment for myelofibrosis (MF) but often loses effectiveness over time, leading to worse overall survival after stopping treatment.
  • The study identified key predictors of survival for RUX-treated MF patients, such as dose, spleen size change, and need for blood transfusions after 6 months of treatment.
  • A new prognostic model called Response to Ruxolitinib After 6 Months (RR6) was developed, categorizing patients into low, intermediate, and high-risk groups for survival, helping guide treatment decisions.
View Article and Find Full Text PDF

Erectile dysfunction (ED) is defined as the inability to attain or maintain penile erection sufficient for successful sexual intercourse. ED carries a notable influence on quality of life, with significant implications for family and social relationships. Because atherosclerosis of penile arteries represents one of the most frequent causes of ED, patients presenting with it should always be investigated for potential coexistent coronary or peripheral disease.

View Article and Find Full Text PDF

We present real-world data on all ruxolitinib-treated myelofibrosis patients in a 10-million-resident region, with a follow-up of 2 years. We found no evidence of an increased risk of developing lymphomas.

View Article and Find Full Text PDF